US Stock MarketDetailed Quotes

Supernus Pharmaceuticals (SUPN)

Watchlist
  • 50.013
  • -0.248-0.49%
Trading Jan 16 11:54 ET
2.87BMarket Cap-147.10P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Supernus Pharmaceuticals (SUPN) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Total revenue
9.34%192.1M
-1.71%165.45M
4.30%149.82M
8.94%661.82M
5.99%174.16M
14.17%175.69M
24.17%168.33M
-6.58%143.64M
-8.95%607.52M
-1.80%164.31M
Operating revenue
9.34%192.1M
-1.71%165.45M
4.30%149.82M
8.94%661.82M
5.99%174.16M
14.17%175.69M
24.17%168.33M
-6.58%143.64M
-8.95%607.52M
-1.80%164.31M
Cost of revenue
7.86%18.97M
-6.08%16.83M
-3.35%15.76M
-7.01%77.91M
32.97%26.1M
-10.30%17.58M
-15.05%17.92M
-30.48%16.31M
-3.95%83.78M
-14.49%19.63M
Gross profit
9.51%173.14M
-1.19%148.63M
5.28%134.06M
11.49%583.91M
2.33%148.06M
17.74%158.11M
31.39%150.41M
-2.28%127.34M
-9.70%523.74M
0.22%144.69M
Operating expense
97.31%233.37M
3.25%136.49M
3.86%136.66M
-0.39%508.36M
0.48%126.3M
-6.57%118.28M
0.71%132.2M
3.79%131.58M
-4.50%510.34M
11.79%125.7M
Selling and administrative expenses
157.59%179.68M
8.90%93.55M
3.96%89.94M
-4.39%321.58M
-2.30%79.41M
-15.66%69.75M
-1.01%85.9M
1.07%86.52M
-10.83%336.36M
9.88%81.28M
-Selling and marketing expense
41.84%77.06M
10.76%65.13M
6.23%63.28M
-0.83%227.29M
-1.24%54.59M
-4.33%54.33M
-1.82%58.8M
4.08%59.57M
--229.19M
--55.28M
-General and administrative expense
565.33%102.62M
4.87%28.42M
-1.05%26.67M
-12.02%94.29M
-4.57%24.82M
-40.48%15.42M
0.79%27.1M
-5.00%26.95M
--107.18M
--26.01M
Research and development costs
1.14%29.37M
-15.54%22.12M
8.01%26.93M
18.78%108.8M
22.70%28.65M
28.17%29.04M
7.40%26.18M
17.53%24.93M
22.86%91.59M
31.35%23.35M
Depreciation amortization depletion
24.82%24.33M
3.54%20.82M
-1.74%19.79M
-5.35%77.98M
-13.41%18.24M
-8.26%19.49M
0.00%20.11M
0.86%20.14M
-0.30%82.39M
1.79%21.07M
-Depreciation and amortization
24.82%24.33M
3.54%20.82M
-1.74%19.79M
-5.35%77.98M
-13.41%18.24M
-8.26%19.49M
0.00%20.11M
0.86%20.14M
-0.30%82.39M
1.79%21.07M
Operating profit
-251.22%-60.23M
-33.34%12.14M
38.89%-2.6M
463.72%75.56M
14.60%21.76M
418.47%39.83M
208.44%18.21M
-220.37%-4.25M
-70.62%13.4M
-40.53%18.99M
Net non-operating interest income expense
-44.44%2.28M
21.30%4.53M
30.30%4.43M
101.59%16.2M
150.60%4.98M
134.04%4.1M
711.52%3.73M
-11.59%3.4M
-45.02%8.04M
146.40%1.99M
Non-operating interest income
-44.44%2.28M
21.30%4.53M
30.30%4.43M
55.02%16.2M
150.60%4.98M
134.04%4.1M
172.48%3.73M
-36.48%3.4M
-51.81%10.45M
-17.25%1.99M
Non-operating interest expense
----
----
----
--0
--0
--0
--0
--0
-65.84%2.42M
--0
Other net income (expense)
-799.54%-7.66M
132.72%6.11M
98.22%-356K
122.81%1.02M
651.27%4.36M
-33.52%1.1M
-3,761.18%-18.67M
-931.32%-19.99M
Special income (charges)
--0
--0
-799.54%-7.66M
132.72%6.11M
98.22%-356K
122.81%1.02M
651.27%4.36M
-33.52%1.1M
-3,761.18%-18.67M
-931.32%-19.99M
-Less：Restructuring and merger&acquisition
--0
--0
799.54%7.66M
-302.77%-6.11M
274.51%356K
-122.81%-1.02M
-651.27%-4.36M
33.52%-1.1M
-197.45%-1.52M
91.51%-204K
-Less:Impairment of capital assets
----
----
----
--0
----
----
----
----
--20.19M
----
Income before tax
-228.95%-57.95M
-36.62%16.67M
-2,499.59%-5.83M
3,434.49%97.87M
2,564.85%26.38M
354.47%44.94M
253.57%26.3M
-97.31%243K
-95.44%2.77M
-97.18%990K
Income tax
-299.15%-12.84M
-191.29%-5.83M
4,938.66%6M
1,552.10%24.01M
6,075.14%11.05M
-75.08%6.45M
139.19%6.39M
101.50%119K
4,440.63%1.45M
-101.92%-185K
Net income
-217.20%-45.12M
12.97%22.5M
-9,637.90%-11.83M
5,512.84%73.87M
1,204.51%15.33M
340.97%38.5M
2,496.63%19.92M
-99.27%124K
-97.83%1.32M
-95.39%1.18M
Net income continuous Operations
-217.20%-45.12M
12.97%22.5M
-9,637.90%-11.83M
5,512.84%73.87M
1,204.51%15.33M
340.97%38.5M
2,496.63%19.92M
-99.27%124K
-97.83%1.32M
-95.39%1.18M
Minority interest income
Net income attributable to the parent company
-217.20%-45.12M
12.97%22.5M
-9,637.90%-11.83M
5,512.84%73.87M
1,204.51%15.33M
340.97%38.5M
2,496.63%19.92M
-99.27%124K
-97.83%1.32M
-95.39%1.18M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-217.20%-45.12M
12.97%22.5M
-9,637.90%-11.83M
5,512.84%73.87M
1,204.51%15.33M
340.97%38.5M
2,496.63%19.92M
-99.27%124K
-97.83%1.32M
-95.39%1.18M
Basic earnings per share
-214.29%-0.8
11.11%0.4
-0.21
6,600.00%1.34
1,507.99%0.28
341.38%0.7
1,900.00%0.36
0
-98.23%0.02
-96.30%0.0174
Diluted earnings per share
-215.94%-0.8
11.11%0.4
-0.21
6,500.00%1.32
1,450.57%0.27
337.93%0.69
1,900.00%0.36
0
-98.08%0.02
-95.95%0.0174
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Total revenue 9.34%192.1M-1.71%165.45M4.30%149.82M8.94%661.82M5.99%174.16M14.17%175.69M24.17%168.33M-6.58%143.64M-8.95%607.52M-1.80%164.31M
Operating revenue 9.34%192.1M-1.71%165.45M4.30%149.82M8.94%661.82M5.99%174.16M14.17%175.69M24.17%168.33M-6.58%143.64M-8.95%607.52M-1.80%164.31M
Cost of revenue 7.86%18.97M-6.08%16.83M-3.35%15.76M-7.01%77.91M32.97%26.1M-10.30%17.58M-15.05%17.92M-30.48%16.31M-3.95%83.78M-14.49%19.63M
Gross profit 9.51%173.14M-1.19%148.63M5.28%134.06M11.49%583.91M2.33%148.06M17.74%158.11M31.39%150.41M-2.28%127.34M-9.70%523.74M0.22%144.69M
Operating expense 97.31%233.37M3.25%136.49M3.86%136.66M-0.39%508.36M0.48%126.3M-6.57%118.28M0.71%132.2M3.79%131.58M-4.50%510.34M11.79%125.7M
Selling and administrative expenses 157.59%179.68M8.90%93.55M3.96%89.94M-4.39%321.58M-2.30%79.41M-15.66%69.75M-1.01%85.9M1.07%86.52M-10.83%336.36M9.88%81.28M
-Selling and marketing expense 41.84%77.06M10.76%65.13M6.23%63.28M-0.83%227.29M-1.24%54.59M-4.33%54.33M-1.82%58.8M4.08%59.57M--229.19M--55.28M
-General and administrative expense 565.33%102.62M4.87%28.42M-1.05%26.67M-12.02%94.29M-4.57%24.82M-40.48%15.42M0.79%27.1M-5.00%26.95M--107.18M--26.01M
Research and development costs 1.14%29.37M-15.54%22.12M8.01%26.93M18.78%108.8M22.70%28.65M28.17%29.04M7.40%26.18M17.53%24.93M22.86%91.59M31.35%23.35M
Depreciation amortization depletion 24.82%24.33M3.54%20.82M-1.74%19.79M-5.35%77.98M-13.41%18.24M-8.26%19.49M0.00%20.11M0.86%20.14M-0.30%82.39M1.79%21.07M
-Depreciation and amortization 24.82%24.33M3.54%20.82M-1.74%19.79M-5.35%77.98M-13.41%18.24M-8.26%19.49M0.00%20.11M0.86%20.14M-0.30%82.39M1.79%21.07M
Operating profit -251.22%-60.23M-33.34%12.14M38.89%-2.6M463.72%75.56M14.60%21.76M418.47%39.83M208.44%18.21M-220.37%-4.25M-70.62%13.4M-40.53%18.99M
Net non-operating interest income expense -44.44%2.28M21.30%4.53M30.30%4.43M101.59%16.2M150.60%4.98M134.04%4.1M711.52%3.73M-11.59%3.4M-45.02%8.04M146.40%1.99M
Non-operating interest income -44.44%2.28M21.30%4.53M30.30%4.43M55.02%16.2M150.60%4.98M134.04%4.1M172.48%3.73M-36.48%3.4M-51.81%10.45M-17.25%1.99M
Non-operating interest expense --------------0--0--0--0--0-65.84%2.42M--0
Other net income (expense) -799.54%-7.66M132.72%6.11M98.22%-356K122.81%1.02M651.27%4.36M-33.52%1.1M-3,761.18%-18.67M-931.32%-19.99M
Special income (charges) --0--0-799.54%-7.66M132.72%6.11M98.22%-356K122.81%1.02M651.27%4.36M-33.52%1.1M-3,761.18%-18.67M-931.32%-19.99M
-Less：Restructuring and merger&acquisition --0--0799.54%7.66M-302.77%-6.11M274.51%356K-122.81%-1.02M-651.27%-4.36M33.52%-1.1M-197.45%-1.52M91.51%-204K
-Less:Impairment of capital assets --------------0------------------20.19M----
Income before tax -228.95%-57.95M-36.62%16.67M-2,499.59%-5.83M3,434.49%97.87M2,564.85%26.38M354.47%44.94M253.57%26.3M-97.31%243K-95.44%2.77M-97.18%990K
Income tax -299.15%-12.84M-191.29%-5.83M4,938.66%6M1,552.10%24.01M6,075.14%11.05M-75.08%6.45M139.19%6.39M101.50%119K4,440.63%1.45M-101.92%-185K
Net income -217.20%-45.12M12.97%22.5M-9,637.90%-11.83M5,512.84%73.87M1,204.51%15.33M340.97%38.5M2,496.63%19.92M-99.27%124K-97.83%1.32M-95.39%1.18M
Net income continuous Operations -217.20%-45.12M12.97%22.5M-9,637.90%-11.83M5,512.84%73.87M1,204.51%15.33M340.97%38.5M2,496.63%19.92M-99.27%124K-97.83%1.32M-95.39%1.18M
Minority interest income
Net income attributable to the parent company -217.20%-45.12M12.97%22.5M-9,637.90%-11.83M5,512.84%73.87M1,204.51%15.33M340.97%38.5M2,496.63%19.92M-99.27%124K-97.83%1.32M-95.39%1.18M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -217.20%-45.12M12.97%22.5M-9,637.90%-11.83M5,512.84%73.87M1,204.51%15.33M340.97%38.5M2,496.63%19.92M-99.27%124K-97.83%1.32M-95.39%1.18M
Basic earnings per share -214.29%-0.811.11%0.4-0.216,600.00%1.341,507.99%0.28341.38%0.71,900.00%0.360-98.23%0.02-96.30%0.0174
Diluted earnings per share -215.94%-0.811.11%0.4-0.216,500.00%1.321,450.57%0.27337.93%0.691,900.00%0.360-98.08%0.02-95.95%0.0174
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Market Insights
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +6.78%
Sample Name
Sample Code
 +2.68%
Sample Name
Sample Code
 +2.37%
4
Broadcom
AVGO
+1.25%
5
Microsoft
MSFT
+1.19%
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +10.46%
Sample Name
Sample Code
 +10.08%
Sample Name
Sample Code
 +8.88%
4
Kingsoft Cloud
KC
+6.85%
5
United Microelectronics
UMC
+6.47%
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More
December FOMC Interest Rate Meeting
[Opportunity Express] MRVL Continues to Bet on Optical Interconnects: Is Now a Good Time to Enter the Market?

- No more -